# Afya (AFYA) — Analyst Forecast

AFYA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/afya/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 3 | 3 | 2 | 8 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 7, 2026 | JP Morgan | Upgraded | Neutral → Overweight | $19.00 |
| Jun 22, 2026 | JP Morgan | Maintained | Neutral | $21.00 |
| Apr 30, 2026 | JP Morgan | Maintained | Neutral | $21.50 |
| Feb 24, 2026 | B of A Securities | Downgraded | Buy → Neutral | $17.00 |
| Feb 13, 2026 | Morgan Stanley | Downgraded | Equal-Weight → Underweight | $16.00 |
| Jan 16, 2026 | UBS | Downgraded | Buy → Neutral | $16.00 |
| Jan 8, 2026 | UBS | Maintained | Buy | $18.00 |
| Jan 7, 2026 | JP Morgan | Downgraded | Overweight → Neutral | $22.00 |
| Sep 8, 2025 | JP Morgan | Upgraded | Neutral → Overweight | $24.50 |
| Sep 8, 2025 | UBS | Upgraded | Neutral → Buy | $19.00 |
| Jul 29, 2025 | Citigroup | Upgraded | Sell → Neutral | $14.00 |
| Jun 12, 2025 | UBS | Maintained | Neutral | $19.50 |
| Mar 11, 2025 | Morgan Stanley | Downgraded | Equal-Weight → Underweight | $17.00 |
| Jan 31, 2025 | Citigroup | Downgraded | Neutral → Sell | $15.00 |
| Jan 17, 2025 | JP Morgan | Maintained | Neutral | $20.50 |
| Dec 3, 2024 | Goldman Sachs | Initiated Coverage | Sell | $16.00 |
| Jun 21, 2024 | Morgan Stanley | Maintained | Equal-Weight | $19.00 |
| Jan 22, 2024 | Morgan Stanley | Downgraded | Overweight → Equal-Weight | $23.00 |
| Nov 27, 2023 | JP Morgan | Downgraded | Overweight → Neutral | $23.00 |
| Oct 13, 2023 | Morgan Stanley | Upgraded | Equal-Weight → Overweight | $20.50 |

## Frequently Asked Questions

### Is AFYA a buy, sell, or hold?

Analysts covering Afya currently average a Buy rating: 3 buy, 3 hold and 2 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on AFYA?

On Oct 7, 2026, JP Morgan upgraded Afya to Overweight with a price target of $19.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).